US Stock MarketDetailed Quotes

EXEL Exelixis

Watchlist
  • 22.870
  • +0.050+0.22%
Close Apr 17 16:00 ET
  • 22.820
  • -0.050-0.22%
Post 16:28 ET
6.93BMarket Cap35.18P/E (TTM)

About Exelixis Company

Exelixis, Inc. operates as an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic. The company was founded by Stelios Papadopoulos on November 15, 1994, and is headquartered in Alameda, CA.

Company Profile

SymbolEXEL
Company NameExelixis
Listing DateApr 11, 2000
Issue Price13.00
Founded1994
CEODr. Michael M. Morrissey, PhD
MarketNASDAQ
Employees1310
Securities TypeOrdinary Shares
Fiscal Year Ends01-03
Address1851 Harbor Bay Parkway
CityAlameda
ProvinceCalifornia
CountryUnited States of America
Zip Code94502
Phone1-650-837-7000
Websitehttp://www.exelixis.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Michael M. Morrissey, PhD
  • Director, President and Chief Executive Officer
  • 16.88M
  • Dr. Dana T. Aftab, PhD
  • Chief Scientific Officer and Executive Vice President, Discovery and Translational Research
  • --
  • Christopher J. Senner
  • Executive Vice President, Chief Financial Officer and Principal Accounting Officer
  • 5.18M
  • Patrick J. Haley
  • Executive Vice President, Commercial
  • 4.65M
  • Jeffrey J. Hessekiel
  • Executive Vice President, General Counsel and Secretary
  • 4.62M
  • Dr. Stelios Papadopoulos,PhD
  • Chairman of the Board
  • 465.07K
  • Dr. Sue Gail Eckhardt, M.D.
  • Director
  • --
  • Dr. Mary C. Beckerle, PhD
  • Director
  • --
  • David Johnson
  • Independent Director
  • --
  • Robert Oliver, M.B.A.
  • Independent Director
  • --
  • Jack L. Wyszomierski, M.S.
  • Independent Director
  • 441.07K
  • Dr. Maria C. Freire, PhD
  • Independent Director
  • 429.57K
  • Dr. George H. Poste, D.V.M.,F.R.S.,PhD
  • Independent Director
  • 431.07K
  • Jacqueline Wright
  • Independent Director
  • 424.60K
  • Dr. Alan M. Garber, M.D.,PhD
  • Independent Director
  • 438.44K
  • Julie Anne Smith
  • Independent Director
  • 453.44K
  • Tomas J. Heyman
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg